Artículos del autor

solaci

Chronic Coronary Syndromes

ACC 2023 | Subanalysis of the REVIVED-BICS Study2

This study demonstrated that coronary angioplasty does not entail any benefit in chronic stable angina over optimal...
solaci -
Chronic Ischemic cardiopathy

ACC 2023 | YELLOW III Study. Effect of Evolocumab on Coronary Plaque Characteristics in Stable Coronary Artery Disease

Dr. Kini presented the results of the YELLOW III Study where she analyzed the effect of evolocumab...
solaci -
Mitral valve

ACC 2023 | TRILUMINATE Pivotal: Edge-to-Edge Treatment in Patients with Tricuspid Regurgitation

Tricuspid regurgitation is a common and impairing disease. Optimal medical therapy (OMT) is limited, valve surgery is...
solaci -
Chronic Ischemic cardiopathy

ACC 2023 | RENOVATE-COMPLEX-PCI: Intravascular Imaging-Guided vs. Angiography-Guided Complex PCI

Patients with complex coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI) have worse clinical outcomes tan...
solaci -
Chronic Coronary Syndromes

ACC 2023 | Complete Revascularization Strategies in patients with ACS and Multivessel Disease

In patients with acute coronary syndrome (ACS) and multivessel disease, complete revascularization is associated with better clinical...
solaci -
Structural heart disease

ACC 2023 | TAVR in Low Risk Patients: 3-Year Outcomes

At present, transcatheter aortic valve replacement (TAVR) has become the gold standard in the US, regardless surgical...
solaci -
Mitral valve

ACC 2023 | COAPT Study: 5 Year Followup after Transcatheter Repair of Secondary Mitral Regurgitation

The five year outcomes of the multicenter open label COAPT (Cardiovascular Outcomes Assessment of the MitraClip Percutaneous...
solaci -
Chronic Ischemic cardiopathy

Microvascular Dysfunction in Symptomatic Patients with Intermediate Coronary Lesions Prognostic impact according to different patterns

Coronary microvascular dysfunction (CMD) is emerging as an important cause of myocardial ischemia, and its role in...
solaci -